ORAMED PHARMACEUTICALS INC (ORMP)
US68403P2039 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | 2020 (2020-8-31) | 2019 (2019-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.05M | 40.50M | 77.20M | 19.30M | 3.30M | |||
| Marketable Securities | 152.99M | 115.30M | 16.90M | 20.60M | 29.00M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 537.00K | 1.40M | 1.20M | 600.00K | 1.00M | |||
| Total Current Assets | 162.58M | 157.10M | 95.30M | 40.50M | 33.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.57M | 1.80M | 900.00K | 200.00K | 0.00 | |||
| Investments And Advances | 56.37M | 2.70M | 31.70M | 3.90M | 1.30M | |||
| Other Non-Current Assets | 27.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Assets | 57.97M | 4.50M | 32.70M | 4.10M | 1.40M | |||
| TOTAL ASSETS | 220.55M | 161.60M | 128.00M | 44.60M | 34.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 51.01M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.32M | 2.20M | 1.30M | 1.10M | 1.20M | |||
| Accounts Payable | 551.00K | 2.20M | 2.60M | 600.00K | 1.30M | |||
| Other Current Liabilities | 325.00K | 1.40M | 2.80M | 2.80M | 2.80M | |||
| Total Current Liabilities | 53.21M | 5.70M | 6.70M | 4.50M | 5.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.44M | 4.70M | 4.80M | 7.20M | 10.00M | |||
| Total Non-Current Liabilities | 3.52M | 4.10M | 5.50M | 7.30M | 10.00M | |||
| TOTAL LIABILITIES | 56.73M | 9.80M | 12.20M | 11.80M | 15.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -157.56M | -163.10M | -114.90M | -92.60M | -81.10M | |||
| Additional Paid In Capital | 320.89M | 314.40M | 230.20M | 125.20M | 100.30M | |||
| Minority Interest | -491.00K | 500.00K | 1.45M | N/A | N/A | |||
| Common Shares | 485.00K | 500.00K | 400.00K | 300.00K | 200.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 40.34M | 39.60M | 35.30M | 23.70M | 17.40M | |||
| Tangible Book Value per Share | 4.06 | 3.83 | 3.28 | 1.39 | 1.11 | |||
| Total Shareholders' Equity | 163.82M | 151.80M | 115.80M | 32.90M | 19.40M | |||
| TOTAL LIABILITIES AND EQUITY | 220.55M | 161.60M | 128.00M | 44.60M | 34.70M | |||
| Statistics | ||||||||
| Current Ratio | 3.06 | 27.56 | 14.22 | 9.00 | 6.28 | |||
| Return On Assets (ROA) | 2.51% | -22.62% | -17.38% | -25.81% | -41.38% | |||
| Return On Equity (ROE) | 3.37% | -24.08% | -19.21% | -34.98% | -74.02% | |||
All data in USD